{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T19:42:27Z","timestamp":1768592547290,"version":"3.49.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"D1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of P.R. China","doi-asserted-by":"crossref","award":["82373790"],"award-info":[{"award-number":["82373790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of P.R. China","doi-asserted-by":"crossref","award":["22220102001"],"award-info":[{"award-number":["22220102001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundations of Zhejiang","award":["RG25H300001"],"award-info":[{"award-number":["RG25H300001"]}]},{"name":"National Key R&D Program of P.R. China","award":["2024YFA1307503"],"award-info":[{"award-number":["2024YFA1307503"]}]},{"name":"Science Research Projects of Hebei Education Department","award":["CYZD202501"],"award-info":[{"award-number":["CYZD202501"]}]},{"name":"Science Research Projects of Hebei Education Department","award":["BJ2025046"],"award-info":[{"award-number":["BJ2025046"]}]},{"name":"Science Research Projects of Hebei Education Department","award":["QN2025145"],"award-info":[{"award-number":["QN2025145"]}]},{"name":"Central Guidance on Local Science & Technology Development Fund of Hebei Province","award":["226Z2605G"],"award-info":[{"award-number":["226Z2605G"]}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206375"],"award-info":[{"award-number":["H2024206375"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation & Development Medical Cooperation Program of Hengrui-Hebei","award":["HR202502095"],"award-info":[{"award-number":["HR202502095"]}]},{"name":"Innovation & Development Medical Cooperation Program of Hengrui-Hebei","award":["202502098"],"award-info":[{"award-number":["202502098"]}]},{"name":"Postdoctoral Fellowship Program of\u00b7CPSF","award":["GZC20252382"],"award-info":[{"award-number":["GZC20252382"]}]},{"DOI":"10.13039\/501100020707","name":"Information Technology Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004835","name":"ZheJiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shijiazhuang Bureau of Science and Technology","award":["241200487A"],"award-info":[{"award-number":["241200487A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Radiopharmaceuticals (RPs) have emerged as a promising group of therapeutic\/diagnostic agents with tremendous pharmaceutical advantages and profitable market value. With the rapid advances in this direction, there is an increasing demand for a knowledge base providing RP-relevant data. However, no such database has been available yet. Herein, a database RadioPharm was therefore developed to depict the pharmaceutical data for 3141 RPs and the radioactive characteristics for the nuclide in each RP. Particularly, our RadioPharm is unique in (i)\u00a0providing the largest number of RPs (including 68 approved, 575 in clinical trials, and 2498 investigative RPs) among the existing databases, (ii)\u00a0offering the comprehensive radioactive characteristics for the radionuclide in each RP, and (iii)\u00a0implementing a multidirectional approach for data retrieval (from diverse perspectives of RP, radionuclide, target, and indication). Because of the important role of all those accumulated data in radiopharmaceutical research, RadioPharm is expected to attract broad interest from research community, which is now fully accessible by all users at\u00a0https:\/\/idrblab.org\/radiopharm\/.<\/jats:p>","DOI":"10.1093\/nar\/gkaf1021","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:25:42Z","timestamp":1760621142000},"page":"D1608-D1615","source":"Crossref","is-referenced-by-count":1,"title":["RadioPharm: the\u00a0database of radiopharmaceuticals"],"prefix":"10.1093","volume":"54","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]},{"name":"School of Pharmacy, Hebei Medical University Department of Pharmacology, , Shijiazhuang 050017 ,","place":["China"]},{"name":"National Key Laboratory of New Pharmaceutical Preparations and Excipients, Hebei Medical University , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusha","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuedong","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]},{"name":"The Key Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingfang","family":"Wei","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7619-2975","authenticated-orcid":false,"given":"Minjie","family":"Mou","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingfan","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-3438","authenticated-orcid":false,"given":"Yintao","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]},{"name":"National Key Laboratory of New Pharmaceutical Preparations and Excipients, Hebei Medical University , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhong","family":"Jia","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]},{"name":"School of Pharmacy, Hebei Medical University Department of Pharmacology, , Shijiazhuang 050017 ,","place":["China"]},{"name":"National Key Laboratory of New Pharmaceutical Preparations and Excipients, Hebei Medical University , Shijiazhuang 050017 ,","place":["China"]},{"name":"The Key Laboratory of Clinical Neurology, Ministry of Education, Hebei Medical University , Shijiazhuang 050017 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8069-0053","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Hebei Medical University Department of Medicinal Chemistry, , Shijiazhuang 050017 ,","place":["China"]},{"name":"College of Pharmaceutical Sciences, The Second Affiliated Hospital, Zhejiang University School of Medicine, State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2026011523115821700_B1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/d41573-024-00016-4","article-title":"Radiopharmaceuticals garner continued M&A investments","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"2026011523115821700_B2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41570-024-00657-4","article-title":"Assembling a new generation of radiopharmaceuticals with supramolecular theranostics","volume":"8","author":"Moreno-Alcantar","year":"2024","journal-title":"Nat Rev Chem"},{"key":"2026011523115821700_B3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S1470-2045(24)00651-X","article-title":"Impact of radiopharmaceutical shortage prompts questions on UK resilience","volume":"25","author":"Wilkinson","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026011523115821700_B4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41587-021-00954-z","article-title":"Drugmakers go nuclear, continuing push into radiopharmaceuticals","volume":"39","author":"Dolgin","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2026011523115821700_B5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2967\/jnumed.120.261016","article-title":"Production and supply of \u03b1-particle-emitting radionuclides for targeted \u03b1-therapy","volume":"62","author":"Radchenko","year":"2021","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B6","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.scib.2024.07.010","article-title":"Locally unlocks prodrugs by radiopharmaceutical in tumor for cancer therapy","volume":"69","author":"Wang","year":"2024","journal-title":"Sci Bull"},{"key":"2026011523115821700_B7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.eururo.2024.09.036","article-title":"Novel radiopharmaceuticals and future of theranostics in genitourinary cancers","volume":"87","author":"Sollini","year":"2025","journal-title":"Eur Urol"},{"key":"2026011523115821700_B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.plrev.2024.03.007","article-title":"PET brain imaging in neurological disorders","volume":"49","author":"Xie","year":"2024","journal-title":"Phys Life Rev"},{"key":"2026011523115821700_B9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jacc.2022.10.034","article-title":"Somatostatin receptor PET\/MR imaging of inflammation in patients with large vessel vasculitis and atherosclerosis","volume":"81","author":"Corovic","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026011523115821700_B10","doi-asserted-by":"publisher","first-page":"e222052","DOI":"10.1148\/radiol.222052","article-title":"68Ga-FAPI PET\/CT for rheumatoid arthritis: a prospective study","volume":"307","author":"Luo","year":"2023","journal-title":"Radiology"},{"key":"2026011523115821700_B11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(24)01919-6","article-title":"177Lu-PSMA-617 for metastatic prostate cancer: aiming for the right spot","volume":"404","author":"Mateo","year":"2024","journal-title":"Lancet"},{"key":"2026011523115821700_B12","doi-asserted-by":"publisher","first-page":"72S","DOI":"10.2967\/jnumed.123.267127","article-title":"Pathway to approval of innovative radiopharmaceuticals in China","volume":"65","author":"An","year":"2024","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B13","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S1470-2045(24)00496-0","article-title":"European Commission approval for Dutch investment in radiopharmaceuticals","volume":"25","author":"Gruber","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026011523115821700_B14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.7150\/thno.93249","article-title":"Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer\u2014from bench to bedside","volume":"14","author":"Arbuznikova","year":"2024","journal-title":"Theranostics"},{"key":"2026011523115821700_B15","doi-asserted-by":"publisher","first-page":"122795","DOI":"10.1016\/j.biomaterials.2024.122795","article-title":"Responsive and traceless assembly of iron nanoparticles and 131I labeled radiopharmaceuticals for ferroptosis enhanced radio-immunotherapy","volume":"313","author":"Shen","year":"2025","journal-title":"Biomaterials"},{"key":"2026011523115821700_B16","doi-asserted-by":"publisher","first-page":"115956","DOI":"10.1016\/j.bios.2023.115956","article-title":"Low cost, high temporal resolution optical fiber-based gamma-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals","volume":"247","author":"Lall","year":"2024","journal-title":"Biosens Bioelectron"},{"key":"2026011523115821700_B17","doi-asserted-by":"publisher","first-page":"30717","DOI":"10.1021\/jacs.4c12254","article-title":"Inductively coupled plasma-mass spectrometry (ICP-MS): an emerging tool in radiopharmaceutical science","volume":"146","author":"Klika","year":"2024","journal-title":"J Am Chem Soc"},{"key":"2026011523115821700_B18","doi-asserted-by":"publisher","first-page":"113757","DOI":"10.1016\/j.jconrel.2025.113757","article-title":"Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications","volume":"382","author":"Meng","year":"2025","journal-title":"J Control Release"},{"key":"2026011523115821700_B19","doi-asserted-by":"publisher","first-page":"102940","DOI":"10.1016\/j.ctrv.2025.102940","article-title":"Radioligand therapy in metastatic breast cancer: harnessing precision oncology","volume":"136","author":"Giugliano","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"2026011523115821700_B20","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s00259-024-06726-6","article-title":"Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties","volume":"51","author":"Hou","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B21","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.2967\/jnumed.121.262749","article-title":"Dosimetry for radiopharmaceutical therapy: current practices and commercial resources","volume":"62","author":"Capala","year":"2021","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B22","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1016\/S1470-2045(24)00030-5","article-title":"Recent advances and impending challenges for the radiopharmaceutical sciences in oncology","volume":"25","author":"Lapi","year":"2024","journal-title":"Lancet Oncol"},{"key":"2026011523115821700_B23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00259-021-05554-2","article-title":"Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model","volume":"49","author":"Liu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.annonc.2023.03.001","article-title":"Next generation radiotheranostics promoting precision medicine","volume":"34","author":"Pomykala","year":"2023","journal-title":"Ann Oncol"},{"key":"2026011523115821700_B25","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.7150\/thno.94788","article-title":"Theranostics and artificial intelligence: new frontiers in personalized medicine","volume":"14","author":"Belge","year":"2024","journal-title":"Theranostics"},{"key":"2026011523115821700_B26","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B27","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B28","doi-asserted-by":"publisher","first-page":"D1372","DOI":"10.1093\/nar\/gkae791","article-title":"DrugMAP 2.0: molecular atlas and pharma-information of all drugs","volume":"53","author":"Li","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B29","first-page":"23N","article-title":"Status of nuclear medicine in Latin America and the Caribbean: IAEA analysis of development in the past 6 years","volume":"62","author":"Orellana","year":"2021","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2967\/jnmt.113.120626","article-title":"A portable database of adverse reactions and drug interactions with radiopharmaceuticals","volume":"41","author":"Gomez","year":"2013","journal-title":"J Nucl Med Technol"},{"key":"2026011523115821700_B31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1060028014558153","article-title":"Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database","volume":"49","author":"Laroche","year":"2015","journal-title":"Ann Pharmacother"},{"key":"2026011523115821700_B32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41570-024-00601-6","article-title":"Harnessing the power of f-block elements in radiopharmaceuticals","volume":"8","author":"Rigby","year":"2024","journal-title":"Nat Rev Chem"},{"key":"2026011523115821700_B33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"2026011523115821700_B34","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00259-024-06680-3","article-title":"Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1","volume":"51","author":"Huang","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1021\/acs.molpharmaceut.4c00897","article-title":"Development of a novel prosthetic click-linker for radioiodination of antibody-based radiopharmaceuticals with high stability and specificity","volume":"22","author":"Im","year":"2025","journal-title":"Mol Pharmaceutics"},{"key":"2026011523115821700_B36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","article-title":"Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group","volume":"50","author":"Salem","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s41181-024-00318-3","article-title":"Novel radionuclides: demand, production and distribution for translational research in Europe","volume":"9","author":"Radzina","year":"2024","journal-title":"EJNMMI Radiopharm Chem"},{"key":"2026011523115821700_B38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s41181-023-00211-5","article-title":"Novel radionuclides for use in nuclear medicine in Europe: where do we stand and where do we go?","volume":"8","author":"Radzina","year":"2023","journal-title":"EJNMMI Radiopharm Chem"},{"key":"2026011523115821700_B39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1088\/0031-9155\/57\/2\/517","article-title":"A free database of radionuclide voxel S values for the dosimetry of nonuniform activity distributions","volume":"57","author":"Lanconelli","year":"2012","journal-title":"Phys Med Biol"},{"key":"2026011523115821700_B40","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B41","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","author":"UniProt","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B42","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B43","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B44","doi-asserted-by":"publisher","first-page":"D1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: therapeutic target database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B45","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1093\/nar\/gkae979","article-title":"Database resources of the National Center for Biotechnology Information in 2025","volume":"53","author":"Sayers","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B46","doi-asserted-by":"publisher","first-page":"D1288","DOI":"10.1093\/nar\/gkac813","article-title":"DrugMAP: molecular atlas and pharma-information of all drugs","volume":"51","author":"Li","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026011523115821700_B47","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1097\/RLU.0000000000005213","article-title":"Planning angiography for 90Y-radioembolization demonstrates a variety of unusual extrahepatic perfusion patterns","volume":"49","author":"Benson","year":"2024","journal-title":"Clin Nucl Med"},{"key":"2026011523115821700_B48","doi-asserted-by":"publisher","first-page":"18230","DOI":"10.1021\/jacs.5c05198","article-title":"Small organic carbonic anhydrase IX ligands from DNA-encoded chemical libraries for tumor-targeted delivery of radionuclides","volume":"147","author":"Muller","year":"2025","journal-title":"J Am Chem Soc"},{"key":"2026011523115821700_B49","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.124.267685","article-title":"Theranostic GPA33-pretargeted radioimmunotherapy of human colorectal carcinoma with a bivalent 177Lu-labeled radiohapten","volume":"65","author":"Vaughn","year":"2024","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B50","doi-asserted-by":"publisher","first-page":"e2413426","DOI":"10.1002\/advs.202413426","article-title":"Ultrasensitive 129Xe magnetic resonance imaging: from clinical monitoring to molecular sensing","volume":"12","author":"Yang","year":"2025","journal-title":"Adv Sci"},{"key":"2026011523115821700_B51","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2967\/jnumed.123.266719","article-title":"ISIT-QA: in silico imaging trial to evaluate a low-count quantitative SPECT method across multiple scanner-collimator configurations for 223Ra-based radiopharmaceutical therapies","volume":"65","author":"Li","year":"2024","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B52","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1200\/JCO.24.00675","article-title":"Machine learning for automated interpretation of fluorodeoxyglucose-positron emission tomography scans in lymphoma","volume":"42","author":"Schoder","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026011523115821700_B53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/RLU.0000000000003472","article-title":"Chylopericardium due to residual lymphangiomyoma detected on 99mTc-sulfur colloid lymphoscintigraphy","volume":"46","author":"Hemrom","year":"2021","journal-title":"Clin Nucl Med"},{"key":"2026011523115821700_B54","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S1470-2045(25)00189-5","article-title":"Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial","volume":"26","author":"Fizazi","year":"2025","journal-title":"Lancet Oncol"},{"key":"2026011523115821700_B55","doi-asserted-by":"publisher","first-page":"113678","DOI":"10.1016\/j.jconrel.2025.113678","article-title":"FAP-targeted delivery of radioiodinated probes: a progressive albumin-driven strategy for tumor theranostics","volume":"382","author":"Li","year":"2025","journal-title":"J Control Release"},{"key":"2026011523115821700_B56","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1007\/s00259-024-06808-5","article-title":"Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer","volume":"51","author":"Wang","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B57","doi-asserted-by":"publisher","first-page":"e231386","DOI":"10.1148\/radiol.231386","article-title":"Efficacy and safety of radiation segmentectomy with 90Y resin microspheres for hepatocellular carcinoma","volume":"311","author":"Sarwar","year":"2024","journal-title":"Radiology"},{"key":"2026011523115821700_B58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1158\/1078-0432.CCR-19-1834","article-title":"Ultrasmall core-shell silica nanoparticles for precision drug delivery in a high-grade malignant brain tumor model","volume":"26","author":"Juthani","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026011523115821700_B59","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.7150\/thno.101922","article-title":"Role of damaged mitochondrial transfer in alpha-particle generator 212Pb radiation-induced bystander effect","volume":"14","author":"Yang","year":"2024","journal-title":"Theranostics"},{"key":"2026011523115821700_B60","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"2026011523115821700_B61","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1038\/s41467-024-49258-1","article-title":"Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer\u2019s disease tauopathies","volume":"15","author":"Lindberg","year":"2024","journal-title":"Nat Commun"},{"key":"2026011523115821700_B62","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1021\/acs.jmedchem.4c00332","article-title":"Discovery of glutamate carboxypeptidase III ligands to compete the uptake of [177Lu]Lu-PSMA-617 in healthy organs","volume":"67","author":"Muller","year":"2024","journal-title":"J Med Chem"},{"key":"2026011523115821700_B63","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s00259-025-07103-7","article-title":"Radiotheranostic landscape: a review of clinical and preclinical development","volume":"52","author":"Tran","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00259-022-06016-z","article-title":"Targeted \u03b1-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound","volume":"50","author":"Watabe","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026011523115821700_B65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ijrobp.2025.01.006","article-title":"Embracing the future of clinical trials in radiation therapy: an NRG oncology CIRO technology retreat whitepaper on pioneering technologies and AI-driven solutions","volume":"122","author":"Xiao","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026011523115821700_B66","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2967\/jnumed.121.262305","article-title":"Dosimetry in radiopharmaceutical therapy","volume":"63","author":"O\u2019Donoghue","year":"2022","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B67","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1158\/2326-6066.CIR-24-1191","article-title":"The effects of clinically relevant radionuclides on the activation of an IFN1 response correlate with radionuclide half-life and linear energy transfer and influence radiopharmaceutical antitumor efficacy","volume":"13","author":"Kerr","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"2026011523115821700_B68","first-page":"1917","article-title":"Feasibility, tolerability, and preliminary clinical response of fractionated radiopharmaceutical therapy with 213Bi-FAPI-46: pilot experience in patients with end-stage, progressive metastatic tumors","volume":"65","author":"Helisch","year":"2024","journal-title":"J Nucl Med"},{"key":"2026011523115821700_B69","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2025.02.015","article-title":"In silico interim adaptation of proton therapy in head and neck cancer by simultaneous dose and linear energy transfer escalation","volume":"122","author":"Garrido-Hernandez","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/54\/D1\/D1608\/64717322\/gkaf1021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/54\/D1\/D1608\/64717322\/gkaf1021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T04:12:04Z","timestamp":1768536724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/54\/D1\/D1608\/8287593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":69,"journal-issue":{"issue":"D1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaf1021","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,6]]},"published":{"date-parts":[[2025,10,16]]}}}